DV
Dividend Vision

CAI — Caris Life Sciences, Inc.

Caris Life Sciences, Inc. (CAI)

Total return is -22.1% over the past 1.2 years, 53.9 points behind SPY at 31.8%. Its deepest 1-year drawdown was 63.0%.

Caris Life Sciences, Inc. is an equity fund focused on a single stock rather than a diversified portfolio of assets. The fund currently carries no distribution frequency, meaning it does not provide regular dividend or income payments to shareholders. This structure appeals primarily to capital appreciation-focused investors rather than those seeking regular income, though limited fund data is available given its recent inception date.

CAI key facts

Asset type
Stock
Asset class
Equity
Inception date
06/18/2025
Distribution frequency
None
Last close
$21.80
Market cap
$6,162,439,168
Average volume
3868841.0
Payout ratio
0.0
P/E ratio
2.3118
Forward P/E
53.1915
EPS
$9.43